SmarTrend identified an Uptrend for Depomed (NASDAQ:DEPO) on March 10, 2010 at $3.19. In approximately 1 week, Depomed has returned 9.4% as of to Read More >>

SmarTrend identified a Downtrend for Depomed (NASDAQ:DEPO) on October 12, 2009 at $4.11. In approximately 5 months, Depomed has returned 24.1% as Read More >>

Depomed, Inc. (NASDAQ:DEPO) announced today that its president and chief executive officer, Carl A. Pelzel will be presenting at the ROTH Read More >>

Depomed, Inc. (DEPO)

Expected next earnings release:

Announcement date: 5/4/2010 - After Market

Earnings Quarter: Q1

Announcement S
          
            Read More
            >>
          
        

Depomed, Inc. (DEPO)

Expected next earnings release:

Announcement date: 3/4/2010 - After Market

Earnings Quarter: Q4

Announcement S
          
            Read More
            >>
          
        

Depomed, Inc. (NASDAQ:DEPO) today reported financial results for the fourth quarter and year ended December 31, 2009.

"The fourth Read More >>

SmarTrend's candlestick pattern scanner has detected a bullish engulfing pattern for shares of Depomed (NASDAQ:DEPO) since the stock cl Read More >>

Depomed, Inc. (NASDAQ:DEPO) announced today that its president and chief executive officer, Carl A. Pelzel will be presenting at the Cowe Read More >>

SmarTrend identified a Downtrend for Depomed (NASDAQ:DEPO) on October 12, 2009 at $4.11. In approximately 5 months, Depomed has returned 33.3% as Read More >>

Depomed, Inc. (DEPO)

Expected next earnings release:

Announcement date: 3/4/2010 - After Market

Earnings Quarter: Q4

Announcement S
          
            Read More
            >>
          
        

Depomed, Inc. (DEPO)

Expected next earnings release:

Announcement date: 3/4/2010 - After Market

Earnings Quarter: Q4

Announcement S
          
            Read More
            >>
          
        

Depomed, Inc. (NASDAQ:DEPO) announced today that it will release fourth quarter and year-end 2009 financial results after the market clos Read More >>

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a commu Read More >>

SmarTrend, the proprietary pattern recognition system, has made available a free sample copy of our premium research report on (NASDAQ:DEP Read More >>

Depomed, Inc. (Nasdaq NM : DEPO) will host a conference call regarding Depomed Comments on DM-1796 Pre-NDA Meeting and Horizant(R) Com Read More >>

Depomed, Inc. (NASDAQ:DEPO) today announced that it has received final meeting minutes from the FDA for a pre-NDA meeting related to DM-1 Read More >>

SmarTrend identified a Downtrend for Depomed (NASDAQ:DEPO) on October 12, 2009 at $4.11. In approximately 4 months, Depomed has returned 38.4% as Read More >>

Depomed, Inc. (DEPO)

Expected next earnings release:

Announcement date: 3/4/2010 - After Market

Earnings Quarter: Q4

Announcement S
          
            Read More
            >>
          
        

SmarTrend identified a Downtrend for Depomed (NASDAQ:DEPO) on October 12, 2009 at $4.11. In approximately 4 months, Depomed has returned 30.7% as Read More >>

Depomed, Inc. (DEPO)

Expected next earnings release:

Announcement date: 3/4/2010 - After Market

Earnings Quarter: Q4

Announcement S
          
            Read More
            >>
          
        

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a commu Read More >>

SmarTrend identified a Downtrend for Depomed (NASDAQ:DEPO) on October 12, 2009 at $4.11. In approximately 4 months, Depomed has returned 30.7% as Read More >>

Depomed, Inc. (NASDAQ:DEPO) announced today that its president and chief executive officer, Carl A. Pelzel, will be presenting at the 12t Read More >>

Depomed, Inc. (NASDAQ:DEPO) announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a U. Read More >>

SmarTrend identified a Downtrend for Depomed (NASDAQ:DEPO) on October 12, 2009 at $4.11. In approximately 4 months, Depomed has returned 27.3% as Read More >>

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a commu Read More >>

Smokefree Innotec, Inc. (PINKSHEETS: SFIO); Depomed, Inc. (NASDAQ:DEPO)

TheWallStreetLeader.com is part of Stock Profiler.US, LLC's New Read More >>

Depomed, Inc. (NASDAQ:DEPO) announced today that it has received a second $500,000 milestone payment under its worldwide license agreemen Read More >>

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a commu Read More >>

Depomed, Inc. (NASDAQ:DEPO) announced today it has received guidance from the FDA in formal meeting minutes from a meeting held in Decemb Read More >>

SmarTrend identified a Downtrend for Depomed (NASDAQ:DEPO) on October 12, 2009 at $4.11. In approximately 3 months, Depomed has returned 21.9% as Read More >>

SmarTrend identified a Downtrend for Depomed (NASDAQ:DEPO) on October 12, 2009 at $4.11. In approximately 3 months, Depomed has returned 24.7% as Read More >>